Literature DB >> 28438709

Characterization of high-resolution Gradient Echo and Spin Echo EPI for fMRI in the human visual cortex at 7T.

Catarina Rua1, Mauro Costagli2, Mark R Symms3, Laura Biagi4, Graziella Donatelli5, Mirco Cosottini6, Alberto Del Guerra7, Michela Tosetti8.   

Abstract

The increased signal-to-noise ratio (SNR) offered by functional Magnetic Resonance Imaging (fMRI) at 7T allows the acquisition of functional data at sub-millimetric spatial resolutions. However, simply reducing partial volume effects is not sufficient to precisely localize task-induced activation due to the indirect mechanisms that relate brain function and the changes in the measured signal. In this work T2* and T2 weighted Echo Planar Imaging (EPI) schemes based on Gradient Recalled Echo (GRE) and Spin Echo (SE) were evaluated in terms of temporal SNR, percent signal change, contrast to noise ratio (CNR), activation volume, and sensitivity and specificity to gray matter. Datasets were acquired during visual stimulation at in-plane resolutions ranging between 1.5×1.5mm2 and 0.75×0.75mm2 targeting the early visual cortex. While similar activation foci were obtained in all acquisitions, at in-plane resolutions of 1.0×1.0mm2 and larger voxel sizes the T2 weighted contrast of SE-EPI allowed the identification of the activation site with better spatial accuracy. However, at sub-millimetric resolutions the decrease in temporal SNR significantly hampered the sensitivity and the extent of the activation site. On the other hand, high resolution T2* weighted data collected with GRE-EPI provided higher CNR and sensitivity, benefiting from the decreased physiological and partial volume effects. However, spurious activations originating from regions of blood drainage were still present in GRE data, and simple thresholding techniques were found to be inadequate for the removal of such contributions. The combination of 2-class and 3-class automated segmentations, performed directly in EPI space, allowed the selection of active voxels in gray matter. This approach could enable GRE-EPI to accurately map functional activity with satisfactory CNR and specificity to the true site of activation.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EPI; Gradient-Echo; High-field; High-resolution; Spin-Echo; fMRI

Mesh:

Year:  2017        PMID: 28438709     DOI: 10.1016/j.mri.2017.04.008

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  5 in total

1.  Improving fMRI in signal drop-out regions at 7 T by using tailored radio-frequency pulses: application to the ventral occipito-temporal cortex.

Authors:  Catarina Rua; Stephen J Wastling; Mauro Costagli; Mark R Symms; Laura Biagi; Mirco Cosottini; Alberto Del Guerra; Michela Tosetti; Gareth J Barker
Journal:  MAGMA       Date:  2017-09-20       Impact factor: 2.310

Review 2.  New acquisition techniques and their prospects for the achievable resolution of fMRI.

Authors:  Saskia Bollmann; Markus Barth
Journal:  Prog Neurobiol       Date:  2020-10-23       Impact factor: 11.685

3.  Addressing challenges of high spatial resolution UHF fMRI for group analysis of higher-order cognitive tasks: An inter-sensory task directing attention between visual and somatosensory domains.

Authors:  Kevin M Aquino; Rodika Sokoliuk; Daisie O Pakenham; Rosa Maria Sanchez-Panchuelo; Simon Hanslmayr; Stephen D Mayhew; Karen J Mullinger; Susan T Francis
Journal:  Hum Brain Mapp       Date:  2018-11-15       Impact factor: 5.038

4.  Correcting for Superficial Bias in 7T Gradient Echo fMRI.

Authors:  Pei Huang; Marta M Correia; Catarina Rua; Christopher T Rodgers; Richard N Henson; Johan D Carlin
Journal:  Front Neurosci       Date:  2021-09-22       Impact factor: 4.677

5.  Forging a path to mesoscopic imaging success with ultra-high field functional magnetic resonance imaging.

Authors:  Kimberly B Weldon; Cheryl A Olman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-11-16       Impact factor: 6.237

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.